An overview of resistance to chemotherapy in osteosarcoma and future perspectives

Osteosarcoma (OS) is the most common type of bone sarcoma. Despite the availability of multimodal treatment with surgery and chemotherapy, the clinical results remain unsatisfactory. The main reason for the poor outcomes in patients with OS is the development of resistance to methotrexate, cisplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Ortega, Dorian Yarih, Cabrera-Nieto, Sara Aileen, Caro-Sánchez, Haydee Sarai, Cruz-Ramos, Marlid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511812/
https://www.ncbi.nlm.nih.gov/pubmed/36176756
http://dx.doi.org/10.20517/cdr.2022.18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511812/
https://www.ncbi.nlm.nih.gov/pubmed/36176756
http://dx.doi.org/10.20517/cdr.2022.18

Ejemplares similares